Vr Adviser, LLC Kal Vista Pharmaceuticals, Inc. Call Options Transaction History
Vr Adviser, LLC
- $414 Million
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding KALV
# of Institutions
139Shares Held
54.4MCall Options Held
1.38MPut Options Held
6K-
Tang Capital Management LLC San Diego, CA4.94MShares$56.3 Million3.7% of portfolio
-
Suvretta Capital Management, LLC New York, NY4.91MShares$56 Million2.48% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA4.89MShares$55.7 Million3.55% of portfolio
-
Vestal Point Capital, LP New York, NY4.75MShares$54.2 Million3.92% of portfolio
-
Capital World Investors Los Angeles, CA3.18MShares$36.2 Million0.01% of portfolio
About KalVista Pharmaceuticals, Inc.
- Ticker KALV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,602,000
- Market Cap $280M
- Description
- KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...